Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

No respite for Indian Indices
Thu, 29 Jan 01:30 pm

As weakness persisted in index heavyweights, Indian share markets continued to trade below the dotted line in the post-noon trading session. Majority of the sectoral indices are trading in the red with banking, power and metal stocks being the biggest losers. However, consumer durables, healthcare and realty are trading in the green.

BSE-Sensex is down 105 points and NSE-Nifty is trading 35 points down. BSE Mid Cap is trading down 0.2%, whereas BSE Small Cap index is trading up marginally. The rupee is trading at 61.41 to the US dollar.

Most power stocks are trading in the red with the key losers being NHPC Ltd, ABB India Ltd and Tata Power. However, Suzlon Energy and Adani Power are trading firm. According to a leading financial daily, Tata Power will acquire group firm Nelco's defense business of Unattended Ground Sensors (UGS) for about Rs 0.8 bn. The UGS business involves supply, installation and servicing of sensors for the Ministry of Defense. Tata Power has entered into a "binding understanding" with Nelco for the deal on a "slump sale basis". The UGS business would be housed in Tata Power's strategic engineering division (SED), which is also a supplier of defense equipment and solutions. Acquisition of the UGS business will provide synergy to the existing business of Tata Power SED. Tata Power is currently trading down by 0.7% on the BSE.

Stocks from the auto sector are trading on a mixed note. Cummins India and M&M are among the major losers. Bosch Ltd and Bharat Forge are among the leading winners. According to a leading business daily, Suzuki Motor Corporation plans to invest Rs.80 bn in Gujarat by setting up three manufacturing units with a total capacity of 750,000 vehicles annually. The first phase of the new plant will entail an investment of Rs 30 bn to make a 250,000 unit assembly line, which will begin operation in the middle of 2017. It will add two more lines to take the capacity to 750,000 vehicles. For Suzuki, India is one of the most important markets and Maruti Suzuki is its largest unit as it contributes about 30% of Suzuki's turnover.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "No respite for Indian Indices". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Agora Research Private Limited.

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Agora Research Private Limited (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.